Our Market Access experts investigate what early access opportunities are available in China to enab...
Read moreThe provision of funding for Early Access Programmes is not ubiquitous. We explore which EU5 countri...
Read morePayer value proposition development and understanding evidence requirements to secure pricing and re...
Read moreAlmost a decade after it's inception, what have we learned from the UK early access to medicines sch...
Read moreMHRA announces UK will introduce new framework aimed at making the manufacture of innovative medicin...
Read moreWe summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...
Read moreWe summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...
Read moreIdentifying EAPs and understanding the opportunities that would best complement manufacturer pricing...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe MHRA awards Innovation Passports to those products it deems innovative, in order for them to be ...
Read more